SAMHD1 expression
|
Ovarian Cancer
|
SAMHD1 expression
|
Ovarian Cancer
|
Platinum alkylating agent Resistant: C3 – Early Trials
|
Platinum alkylating agent Resistant: C3 – Early Trials
|
SAMHD1 expression
|
NSCLC
|
SAMHD1 expression
|
NSCLC
|
Platinum alkylating agent Resistant: C3 – Early Trials
|
Platinum alkylating agent Resistant: C3 – Early Trials
|
SAMHD1 expression
|
Breast Cancer
|
SAMHD1 expression
|
Breast Cancer
|
capecitabine Resistant: C3 – Early Trials
|
capecitabine Resistant: C3 – Early Trials
|
SAMHD1 expression
|
Ovarian Cancer
|
SAMHD1 expression
|
Ovarian Cancer
|
gemcitabine Resistant: C3 – Early Trials
|
gemcitabine Resistant: C3 – Early Trials
|
SAMHD1 expression
|
Ovarian Cancer
|
SAMHD1 expression
|
Ovarian Cancer
|
Platinum alkylating agent + gemcitabine Resistant: C3 – Early Trials
|
Platinum alkylating agent + gemcitabine Resistant: C3 – Early Trials
|